Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 Patients
Medicine
[키워드] Administered
adverse event
alveolar
amniotic
amniotic fluid (AF)
ARDS (Acute Respiratory Distress Syndrome)
Care
caused
Chest
Clinical outcome
clinical status
Complication
coronavirus
COVID-19
COVID-19 infection
Critical care
Critically ill patient
delirium
develop
diagnosed with COVID-19
efficacious therapeutic
excessive immune response
Exosomes
Extracellular
Extracellular vesicles
feasible
Flow
fraction
Hospitalized
ICU
Ill
improvement
Improvements
Inflammatory biomarker
Intervention
lung
nanoparticle
novel coronavirus disease
organ damage
outbreak
outcome
Patient
PROTECT
resolved
Respiratory failure
Safe
SOFA score
suppress
therapeutic
therapy
Treatment
Vesicle
was performed
[DOI] 10.3389/fmed.2021.583842 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.583842 PMC 바로가기 [Article Type] Medicine